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Understanding how class switch recombination (CSR) is regulated to produce immunoglobulin E (IgE) has become fundamental
because of the dramatic increase in the prevalence of IgE-mediated hypersensitivity reactions. CSR requires the induction of the
enzyme AICDA in B cells. Mutations in AICDA have been linked to Hyper-IgM syndrome (HIGM2), which shows absence of
switching to IgE as well as to IgG and IgA. Although isolated IgE deﬁciency is a rare entity, here we show some individuals with
normal serum IgM, IgG, and IgA levels that had undetectable total serum IgE levels. We have analyzed the AICDA gene in these
individuals to determine if there are mutations in AICDA that could lead to selective IgE deﬁciency. Conformational sensitive
gel electrophoresis (CSGE) and sequencing analysis of AICDA coding sequences demonstrated sequence heterogeneity due to
5923A/G and 7888C/T polymorphisms, but did not reveal any novel mutation that might explain the selective IgE deﬁcit.
Copyright © 2008 Sergio Roa et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The prevalence of immunoglobulin-E-(IgE-) mediated
hypersensitivity reactions, such as allergic asthma, rhinitis,
hay fever, or food allergy, has been dramatically increasing
for the last decades [1]. Total serum IgE levels tend to
be higher in allergic patients compared with nonallergic
individuals, although the diagnostic value of total serum
IgE is limited [2] and the presence of speciﬁc IgE is not
always equal to disease [3, 4]. The eﬀectiveness of humoral
immune responses depends on the capacity of B-cells to
class switch from IgM to the other downstream isotypes.
Class switch recombination (CSR) is a recombinational
process that requires the introduction of double-stranded
DNA breaks into the donor μ switch region, that is 5  to
the μ constant regions, and into a recipient γ,ε,o rα switch
region that is 5  to each of those constant regions. The
antibody repertoire is shaped not only by CSR, but also
by somatic hypermutation (SHM) to create higher aﬃnity
antibodies. Both processes occur in centroblast B cells in
the germinal centers of secondary lymphoid organs [5, 6].
A major break through in the understanding of how these
processes are initiated was provided by the discovery of the
mutagenic enzyme activation-induced cytidine deaminase
(AICDA, also known as AID) [7–9].
Class switching to IgE requires two signals: the ﬁrst is
delivered by IL-4 and IL-13, and the second is provided by
the interaction of the B-cell surface antigen CD40 with its
ligand CD154 (CD40L) [10], which is transiently expressed
on activated T cells and synergizes with IL-4 to induce
AICDA-encoding messenger RNA and AICDA protein [11].
When initiating IgE switching, IL-4 induces the binding
of STAT6 to a site in the 5  region of the AICDA gene,
and CD40 activation induces the binding of NF-kB to two
sites in the same region of the AICDA gene [12]. Synergy
between IL-4 and CD40 might be required to achieve
a threshold level of AICDA expression for CSR to IgE
[13]. Several groups have reported an association between
serum IgE levels, allergic disorders, and polymorphisms in
the AICDA gene [14–16], although this association is not
completely understood and might vary among populations
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Defects in CSR have been described in hyperim-
munoglobulin M (IgM) syndromes, which are primary
immunodeﬁciencies characterized by normal or elevated
serum IgM levels with the absence of other isotypes [19].
A group of patients with the autosomal recessive form
of the hyper-IgM syndrome (HIGM2) are known to have
mutations in the AICDA gene [7, 20]. Since some of these
mutations in AICDA are not in its active site, it has been
assumed that they related to the targeting of AICDA. This
is born out by the fact that mutations and deletions in
the C-terminal region of AICDA result in the loss of class
switching while SHM persists [21, 22], whereas mutations
in the N-terminal part of AICDA lead to the loss of SHM
and retention of CSR [23]. This suggests that there may
be AICDA associated proteins that are required for the
targeting to switch regions and raises the possibility that
diﬀerent proteins associate with AICDA to target it to
each of the switch regions. One way to screen for such
interactions is to search for mutations in AICDA that lead
to selective CSR impairment in clinical groups with speciﬁc
immunodeﬁciencies.
Isolated IgE deﬁciency is a rare entity and its association
to clinical relevant immunodeﬁciency is controversial [24–
29]. As opposed to hyper-IgM syndromes, the levels of
other isotypes are normal in individuals with isolated IgE
deﬁciency, suggesting the possibility of a selective CSR defect
to this isotype. In the present study, we had the opportunity
to investigate a rare group of 9 individuals with isolated IgE
deﬁciency. In an attempt to further understand the contri-
butions of AICDA to the mechanisms underlying CSR and
IgE production, we performed a molecular characterization
of AICDA gene in these subjects, to assess whether speciﬁc
defects in AICDA are related to isolated deﬁciency of total
serum IgE levels.
2. MATERIALS AND METHODS
2.1. Subjects
This study was performed in 9 patients with serum IgE
levels below 2kU/1 selected from a total of 643 patients
that were referred during two consecutive years to the
Allergy Department of the University Hospital of Sala-
manca (Spain) for an allergic evaluation. All of them gave
informed written consent and the study was performed
following the recommendations of the Ethical Committee
of the University Hospital of Salamanca. Total serum IgE
levels were measured in all patients by ﬂuorescent enzyme
immunoassay (ImmunoCAP total IgE, Phadia, Uppsala,
Sweden), which exhibits a measuring range for undiluted
serumof2–5000kU/l.SinceIgElevelsvarygreatlyinpatients
younger than 15 years, only patients older than 18 years
were selected. IgE deﬁciency was deﬁned as a total serum
IgE level below 2kU/l. Skin prick testing was performed
following the European Academy of Allergology and Clinical
Immunology (EAACI) recommendations [30] with a battery
of common aeroallergens that included D. pteronisynuss, D.
farinae, L. destructor, T. putrescentiae, A. siro, G. domesticus,
E. maynei, mix of grasses, mix of trees, P. judaica, C.
album, A. vulgaris, P. lanceolata, O. europaea, A. alternata,
C. herbarum, P. notatum, A. fumigatus, dog, cat, hamster,
horse, rabbit dander, and cockroach (ALK-Abell´ o, Madrid,
Spain). Histamine (10mg/mL) was used as positive control
and saline was used as negative control. Before skin testing,
antihistamines were discontinued according to published
guidelines. Skin tests were considered positive if at least
one wheal reaction of more than 3mm of diameter after
subtraction of the negative control was observed. IgM, IgG,
and IgA levels were measured in all patients with IgE level
below2kU/l,bynephelometry(DadeBehringInc,Deerﬁeld,
Ill, USA).
2.2. DNAextraction,PCRprimersdesign,and
ampliﬁcationreactions
GenomicDNAwasextractedfromperipheralbloodlympho-
cytesusingastandardphenol-chloroformprotocol.Exons1–
5 and intronic ﬂanking sequences of the AICDA gene were
ampliﬁed using polymerase chain reaction (PCR). 3  ends
of all primers were designed to be located at least 45 base
pair (bp) away from the splice junctions or the stop codon
(Table 1). Ampliﬁcations were performed using 250ng of
DNA template, 1μLo fe a c h1 0 μMp r i m e ra n d2 1 μLo f
2xPCR Master Mix (Promega, Madison, Wis, USA) in a ﬁnal
volumeof25μLinanGeneAmpPCRSystem9700automated
thermocycler (PE Applied Biosystems, Foster City, Calif,
USA) with the same conditions: 4 minutes of denaturation
at 94◦C, followed by 30 cycles with a denaturation step of 1
minute at 94◦C, an annealing step of 1 minute at 55◦C, an
extension step of 1 minute at 72◦C, and a ﬁnal 10 minutes
extension at 72◦C. Ampliﬁcation of the samples was checked
by electrophoresis in 2% agarose gels.
2.3. MutationdetectionbyCSGE(conformational
sensitivegelelectrophoresis)
Mutation detection enhancement (MDE) gels (Cambrex,
Rockland, Me, USA) were used to analyze PCR products
for the presence of mutations in the AICDA gene. 10μLo f
the PCR product were combined with 2μL of 6xTriple dye
loading buﬀer (Cambrex, Rockland, Me, USA). The samples
were heated at 95◦C for 5 minutes, slowly cooled to 37◦C
and run on 0.5xMDE gels containing 0.6xTris-Borate-EDTA
(TBE) buﬀer (1xTBE = 0.089M Tris-Borate, 0.002M EDTA,
and pH 8.3). Gels were run overnight in 0.6xTBE at 20V/cm
for 12–18 hours, depending on the size of the PCR product.
MDE gels were stained using PlusOne DNA silver staining
kit (Amersham Biosciences, Uppsala, Sweden) according to
the manufacturer’s instructions. Heteroduplex bands were
visualized on a transilluminator and documented.
2.4. Sequencing
Whenever a heteroduplex was detected, nucleotide sequence
information was determined by direct sequencing of the
PCR products. The genotyping of intron 2 (5923A/G) and
exon 4 (7888C/T) polymorphisms were performed by direct
sequencing in all cases. The same primers designed forSergio Roa et al. 3
Table 1: AICDA primers, PCR conditions, and size of the fragments used in the study.
Exon Primer designation Primer sequence Annealing Product size (bp)
Temperature (◦C) Position∗
1 hAID1F 5 -GCCGTTGGGGTACCTGGTGG-3 
55
−179 280
hAID1R 5 -ATGAGAGAAAGGGATAGCTA-3  +100
2 hAID2F 5 -AGCCCAAGTAATGACTTCCTTA-3 
55 +5661 321
hAID2R 5 -ACCATCAGCAGGTGGCTCTAA-3  +5981
3 hAID3F 5 -GACTAAGGCTACCAGAGCCG-3 
55 +7221 440
hAID3R 5 -GCCCACTTCTTCCCCTCGAG-3  +7660
4 hAID4F 5 -GTGAATGGCTCAGAGACAAGG-3 
55 +7716 364
hAID4R 5 -ATCAGATGAAAACTGAGAGTGA-3  +8079
5 hAID5F 5 -GTTACAAAGCCATCCACTCAG-3 
55 +8334 237
hAID5R 5 -GAGAAGACTTGAAGGACTG-3  +8570
∗Position of primers is according to GENBANK sequence Accession Number AB040430.1.
PCR ampliﬁcation were used for the sequencing analysis of
the PCR products (Table 1). PCRs fragments were puriﬁed
withMicroSpinS-300HRColumns(AmershamBiosciences,
Piscataway, Nj, USA) and sequenced using d-Rhodamine
Dye terminator cycle sequencing kit and analysed with ABI
Prism 377 genetic analyser (Applied Biosystems, Inc).
3. RESULTS
From a total of 643 patients that underwent determination
of total serum IgE, 9 patients had IgE levels below 2kU/l
(1.4%). Strikingly, total serum IgM, IgG, and IgA levels
were normal in all of them (Table 2). None of these patients
had personal history of allergy or atopy and all of them
had negative skin tests. No previous personal or familial
history suggesting immunodeﬁciency was recorded in any of
them.Nevertheless,anincreaseinnonallergicreactiveairway
diseases (i.e., nonallergic asthma) and autoimmunity (i.e.,
hyperthyroidism and dermatomyositis) was observed.
MDE gel electrophoresis of PCR products spanning
exons 1, 3, and 5 from AICDA gene revealed germ-line con-
ﬁgurations. As expected, due to 5923A/G and 7888C/T poly-
morphisms[16],severalheteroduplexpatternsweredetected
in PCR products spanning exons 2 and 4, respectively.
Sequence analysis of both regions in all patients identiﬁed
diﬀerent alleles for the polymorphic sites (Figure 1) but did
not reveal any novel mutation.
Distributions of genotypes of the 5923A/G and 7888C/T
polymorphisms were consistent with Hardy-Weinberg equi-
librium. The distribution of genotypes of these polymor-
phisms in the 9 patients is shown in Table 3. We have studied
a small number of patients because of the low prevalence of
IgE deﬁciency. Although this is an important limitation to
the study of this condition, the genotype frequencies of the
synonymous 7888C/T polymorphism at exon 4 (Reference
SNP Identiﬁcation rs2028373 [31]) did not deviate from
expected values previously reported [16, 18]. In the case
of the AICDA intronic 5923A/G polymorphism, genotype
frequencies were similar to those reported in NCBI single
nucleotide polymorphism database, according to Reference
SNP Identiﬁcation rs2518144 [31]. The diplotype distribu-
tion of both polymorphisms was heterogeneous. No speciﬁc
haplotype was detected in this population.
4. DISCUSSION
The level of serum IgE is usually 10,000 to 50,000-fold
lower than the level of serum IgG and its production is
tightly regulated. The overall role of IgE in immunity is
not completely understood, but it seems to be involved in
the defence against parasitic infections. Reports about IgE
deﬁciency are limited and their association with clinically
relevant immunodeﬁciency is still controversial [24–29]. We
have evaluated the clinical characteristics of a group of
patients with serum IgE levels below 2kU/l, but normal IgM,
IgG, and IgA serum levels (Table 2). In our setting of an
outpatient allergy clinic, only 9 out of 643 (1.4%) patients
that underwent IgE determination had serum total IgE levels
under the detection threshold (2kU/l). There is limited
information about prevalence of IgE deﬁcits. Levy et al. [32]
foundanincidenceof16.5%,buttheirthresholdwas10kU/l,
and Smith et al. [29] found 10.5% of patients with IgE levels
below 2.5kU/l. Our incidence is lower probably due to the
lower threshold that we used. Although controversial, there
are some reports on local IgE production [33] and therefore
we cannot absolutely discard the possibility of local CSR to
IgE in tissue. Nevertheless we believed that this fact is highly
improbable because it has been shown that patients with
local production of speciﬁc IgE did not have undetectable
total IgE levels and they suﬀered from perennial rhinitis,
usually with seasonal symptoms [34].
None of the patients with IgE deﬁciency included in
our series showed personal or familial clinical data of
immunodeﬁciency but three patients presented nonallergic
asthma, and autoimmune disorders were present in two
patients. This is in agreement with the study of Smith et al.
[29], which found a higher prevalence of both conditions in
patients with serum IgE levels below 2.5kU/l, suggesting the4 Clinical and Developmental Immunology
Table 2: Phenotype characteristics of patients with IgE hypogammaglobulinemia.
No. Sex/Age Clinical diagnosis IgE IgG IgA IgM History of immunodeﬁciency/
(kU/l) (mg/dl) (mg/dl) (mg/dl) autoimmunity
1F / 5 7 N o r m a l <2 1300 1822 147 No/No
2 F/37 Non allergic asthma <2 735 156 226 No/No
3F / 6 5 N o r m a l <2 954 221 63 No/No
4 F/28 Contact dermatitis <2 700 108 157 No/No
5F / 5 7 N o r m a l <2 1210 245 84 No/hyperthyroidism
6 M/44 Chronic urticaria <2 859 257 69 No/No
7 F/59 Non allergic asthma <2 1080 242 73 No/No
8 M/48 Non allergic asthma <2 809 200 58 No/No
9F / 5 7 N o r m a l <2 1540 353 234 No/dermatomyositis
F: female, M: male.
A   A   A   G    T  C    A   G   C     T   T    T A   A   A   G    T   C   N   G  C     T    T    T A   A   A   G    T   C   G   G  C     T    T    T
Homozigote A Heterozigote A/G Homozigote G
(a)
A    A    C    C    A    C    G    A     A    A   G A    A    C    C    A    N   G    A    A    A   G A    A    C     C    A   T    G    A    A    A    G
Homozigote C Heterozigote C/T Homozigote T
(b)
Figure 1: Sequencing analysis of regions 2 and 4 from human AICDA gene, where genetic variants were detected by heteroduplex. Panels
show sequences of the diﬀerent alleles corresponding to 5923A/G polymorphism at the 3 -ﬂanking region of (a) exon 2 and 7888C/T
polymorphism at (b) exon 4 of the AICDA gene. Arrows indicate the polymorphic sites.
existence of common genetic factors that may predispose to
both IgE deﬁciency and autoimmunity. Other authors have
proposedthatderegulationofmoleculesandsignalsthatplay
a key role in B-cell activation and terminal diﬀerentiation
could be involved in initiating or maintaining autoimmunity
[35].
AICDA plays an essential role in CSR, which is impaired
in both AICDA-deﬁcient mice [8] and in patients with
HIGM2syndrome[7,20].AnassociationbetweenserumIgE
levels and AICDA has been previously reported, and several
studies have shown the association between polymorphisms
in the AICDA gene and allergic disorders [14–16], although
this association is not completely understood and might
vary among populations [17, 18]. Serum IgE levels have
an inherited non-Mendelian component, although there is
one report that showed an autosomal dominant pattern
with a variable degree of penetrance in patients with IgE
deﬁciency [28]. Exploration of genetic regulation in IgE
responses, based on both candidate gene approaches and
linkage studies has led to the report of several sets of
molecular and cellular interactions that are essential for IgE
synthesis [36]. Nevertheless, no study of susceptibility lociSergio Roa et al. 5
Table 3: Genotype distribution of 5923A/G and 7888C/T polymor-
phisms from AICDA gene in our population.
Patient 5923A/G 7888C/T
1G G T T
2A G C T
3A G T T
4G G C T
5G G T T
6A A C T
7A G C C
8G G C T
9G G T T
has been performed on patients with undetectable serum IgE
levels. Here, we have examined whether mutations in the
AICDA gene might explain the phenotype of our cohort of
patients with isolated IgE deﬁciency and aﬀect the speciﬁcity
of switching towards IgE production. We have identiﬁed two
previously described polymorphisms (intron 2 5923A/G and
exon 4 7888C/T) in the AICDA gene, but no defects in the
AICDA coding or ﬂanking regions account for the IgE deﬁcit
inourcohort.Previousreportsandpublicdatabasesonthese
polymorphisms did not show any evident association with
AICDA expression levels, splicing or function. We cannot
rule out that mutations in the promoter region, epigenetic
changes or posttranslational modiﬁcations in AICDA could
be involved in the decrease of IgE levels. In addition, other
factors involved in immunoglobulin class switching besides
AICDA might be implicated. The characterization of such
factors would be important in understanding the speciﬁc
targeting of AICDA to the ε switch region and the molecular
basis of isolated IgE deﬁciency.
5. CONCLUSIONS
The exploration of various types of clinical immunodeﬁ-
ciencies provides a unique opportunity to better under-
stand the molecular basis of immunoglobulin class switch
recombination.Here,weevaluatedtheclinicalcharacteristics
of a cohort of patients with isolated IgE deﬁciency, which
exhibited a higher prevalence of nonallergic asthma and
autoimmunity disorders. We analyzed AICDA, the master
gene required for CSR, in these patients to see if there were
speciﬁc mutations that would result in impaired CSR and
explain their undetectable serum IgE levels. Two previously
described polymorphisms (intron 2 5923A/G and exon 4
7888C/T), but no mutation, were detected in AICDA gene.
FurthersearchforalternativecausesofisolatedIgEdeﬁciency
could open new ways to understand speciﬁc CSR and IgE
production.
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